[Use of antithrombotic drugs in internal medicine].
D000787:Angina Pectoris / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000188:drug therapy; D003374:Coumarins / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy; D011317:Priapism / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D007189:Indans; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator
Anwendung antithrombotischer Medikamente in der Inneren Medizin.